State dementia oversight efforts must include representatives from entire long-term care continuum, experts...
By
Kimberly Bonvissuto
Jul 10, 2024
The potential creation of a permanent state division and advisory committee dedicated to Alzheimer’s disease and related disorders has won praise from Pennsylvania’s senior living industry advocates,...
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...